| 孔令春.吲哚美辛的临床应用进展[J].海峡药学, 2006, 18(2): 116-118. doi: 10.3969/j.issn.1006-3765.2006.02.063 |
| 董宗祈.非甾体抗炎药的研究进展及其临床应用[J].河南诊断与治疗杂志, 2000, 14(3): 140-141. |
| 雷曙光, 罗永煌, 陈君.吲哚美辛研究概况及其在动物上的应用[J].中国动物保健, 2011, 13(1): 14-17. doi: 10.3969/j.issn.1008-4754.2011.01.007 |
| 刘红, 李国珍, 葛泉丽.非甾体抗炎药的作用机制及进展[J].实用医技杂志, 2003, 10(4): 401-402. doi: 10.3969/j.issn.1671-5098.2003.04.124 |
| DIMIZA F, PAPADOPOULOS A N, TANGOULIS V, et al. Biological Evaluation of Non-Steroidal Anti-Inflammatory Drugs-Cobalt(Ii) Complexes[J]. Dalton Transactions, 2010, 39(19): 4517. doi: 10.1039/b927472c |
| YALKOWSKY S H, DANNENFELSER R M. Database of Aqueous Solubility[M]. Version 5 ed. Tucson: University of Arizona Tucson, 1992. |
| BERGE S M, BIGHLEY L D, MONKHOUSE D C. Pharmaceutical Salts[J]. Journal of Pharmaceutical Sciences, 1977, 66(1): 1-19. |
| RAUTIO J, KUMPULAINEN H, HEIMBACH T, et al. Prodrugs: Design and Clinical Applications[J]. Nature Reviews Drug Discovery, 2008, 7(3): 255-270. |
| LOFTSSON T, DUCHENE D. Cyclodextrins and Their Pharmaceutical Applications[J]. International Journal of Pharmaceutics, 2007, 329(1-2): 1-11. doi: 10.1016/j.ijpharm.2006.10.044 |
| LAVASANIFAR A, SAMUEL J, KWON G S. Poly(Ethylene Oxide)-Block-Poly(L-Amino Acid) Micelles for Drug Delivery[J]. Advanced Drug Delivery Reviews, 2002, 54(2): 169-190. doi: 10.1016/S0169-409X(02)00015-7 |
| LI G L, LIU J Y, PANG Y, et al. Polymeric Micelles with Water-Insoluble Drug as Hydrophobic Moiety for Drug Delivery[J]. Biomacromolecules, 2011, 12(6): 2016-2026. doi: 10.1021/bm200372s |
| MUELLER E A, KOVARIK J M, VAN BREE J B, et al. Improved Dose Linearity of Cyclosporine Pharmacokinetics from a Microemulsion Formulation[J]. Pharmaceutical Research, 1994, 11(2): 301-304. doi: 10.1023/A:1018923912135 |
| CANNON J, SHI Y, GUPTA P. Emulsions, Microemulsions, and Lipid-Based Drug Delivery Systems for Drug Solubilization and Delivery-Part I[M] //Water-Insoluble Drug Formulation. Second Edition. London: CRC Press, 2008: 195-226. |
| QIN L H, NIU Y W, WANG Y M, et al. Combination of Phospholipid Complex and Submicron Emulsion Techniques for Improving Oral Bioavailability and Therapeutic Efficacy of Water-Insoluble Drug[J]. Molecular Pharmaceutics, 2018, 15(3): 1238-1247. doi: 10.1021/acs.molpharmaceut.7b01061 |
| FATOUROS D G, DEEN G R, ARLETH L, et al. Structural Development of Self Nano Emulsifying Drug Delivery Systems (SNEDDS) during in Vitro Lipid Digestion Monitored by Small-Angle X-Ray Scattering[J]. Pharmaceutical Research, 2007, 24(10): 1844-1853. doi: 10.1007/s11095-007-9304-6 |
| RABINOW B E. Nanosuspensions in Drug Delivery[J]. Nature Reviews Drug Discovery, 2004, 3(9): 785-796. doi: 10.1038/nrd1494 |
| POTTA S G, MINEMI S, NUKALA R K, et al. Development of Solid Lipid Nanoparticles for Enhanced Solubility of Poorly Soluble Drugs[J]. Journal of Biomedical Nanotechnology, 2010, 6(6): 634-640. doi: 10.1166/jbn.2010.1169 |
| CHIOU W L, RIEGELMAN S. Pharmaceutical Applications of Solid Dispersion Systems[J]. Journal of Pharmaceutical Sciences, 1971, 60(9): 1281-1302. doi: 10.1002/jps.2600600902 |
| BROUGH C, WILLIAMS R O Ⅲ. Amorphous Solid Dispersions and Nano-Crystal Technologies for Poorly Water-Soluble Drug Delivery[J]. International Journal of Pharmaceutics, 2013, 453(1): 157-166. doi: 10.1016/j.ijpharm.2013.05.061 |
| KHODER M, ABDELKADER H, ELSHAER A, et al. The Use of Albumin Solid Dispersion to Enhance the Solubility of Unionizable Drugs[J]. Pharmaceutical Development and Technology, 2018, 23(7): 732-738. doi: 10.1080/10837450.2017.1364267 |
| WANG Y Z, SUN L Z, JIANG T Y, et al. The Investigation of MCM-48-Type and MCM-41-Type Mesoporous Silica as Oral Solid Dispersion Carriers for Water Insoluble Cilostazol[J]. Drug Development and Industrial Pharmacy, 2014, 40(6): 819-828. doi: 10.3109/03639045.2013.788013 |
| 李永亮, 杨世颖, 胡堃, 等.吲哚美辛溶剂合物多晶型现象与表征方法[J].医药导报, 2015, 34(6): 785-790. doi: 10.3870/yydb.2015.06.023 |